The aims of this study were to identify risk factors associated with delirium in hospitalized persons with dementia, and to describe immediate and post-hospital (1\&3 months) trajectory of cognitive decline and associated outcomes in persons with dementia who develop delirium. It was hypothesized that factors such as CNS-active medications, urinary tract infection, stage of dementia, pain, activity level, and dehydration would be associated with an increased risk of delirium and delirium severity in patients with dementia compared to dementia patients without delirium. It was also hypothesized that persons with DSD will have worse outcomes (longer hospital length of stays, decreased functional status, a steeper negative slope of cognitive decline) than dementia patients without delirium. Lastly, it was hypothesized that higher delirium severity would be associated with poorer outcomes in persons with dementia. The long-term objectives were to use the results from this study to design and test an intervention strategy to improve early recognition, management, prevention, and outcomes in persons with DSD.
It is well known that persons with dementia are at increased risk of developing delirium or acute confusional state. Further, current evidence suggests that delirium may worsen the prognosis of dementia, may alter the clinical course and trajectory of cognitive decline, and may be associated with substantially worse long-term outcomes. This study was a prospective cohort study design involving 165 hospitalized subjects with dementia who were 65 and older and included a three month follow up period. Aims for the study included: 1) to identify risk factors for DSD, and 2) to describe post-hospital outcomes and the trajectory of cognitive decline for DSD, which will justify the development of appropriate preventative and management strategies for delirium in patients with dementia. Delirium was assessed daily from admission to discharge and then at one and three month follow-ups. The potential risk factors being examined were 1) polypharmacy (central nervous system-active medications, number of medications, new medications added), 2) physical stressors (urinary tract infection, pain, dehydration), and 3) environmental stressors (bedrest, restraints, room changes). Outcomes were assessed by research study staff blinded to the study aims.
Study Type
OBSERVATIONAL
Enrollment
308
Mount Nittany Medical Center
State College, Pennsylvania, United States
Change in Delirium status during hospital stay
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Time frame: Participants will be assessed daily until discharge (duration of hospitalization), which is expected to be about 5 days
Change in Delirium status at 1 month after discharge
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Time frame: Participants will be assessed 1 month after date of hospital discharge
Change in Delirium status at 3 months after discharge
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Time frame: Participants will be assessed 3 months after date of hospital discharge
Hospitalization Length of Stay
Time frame: Duration of hospitalization, expected to be about 5 days
Change in Functional Status during hospital stay
Measured using the KATZ ADL Scale and Lawton Index of Daily Living
Time frame: Daily until discharge, expected to be about 5 days
Change in Functional Status at 1 month after discharge
Measured using the KATZ ADL Scale and Lawton Index of Daily Living
Time frame: Participant will be assessed 1 month after date of hospital discharge
Change in Functional Status at 3 months after discharge
Measured using the KATZ ADL Scale and Lawton Index of Daily Living
Time frame: Participant will be assessed 3 months after date of hospital discharge
Change in Cognitive Decline during hospital stay
MMSE and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) used to measure cognition
Time frame: Daily until discharge, expected to be about 5 days
Change in Cognitive Decline at 1 month after discharge
MMSE and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) used to measure cognition
Time frame: Participant will be assessed 1 month after date of hospital discharge
Change in Cognitive Decline at 3 months after discharge
MMSE and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) used to measure cognition
Time frame: Participant will be assessed 3 months after date of hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.